# SHINE Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/shine-technologies

- Industry: Medical Devices & Equipment
- Headquarters: Janesville, US
- Website: www.shinefusion.com
- Total disclosed funding: $150M
- Latest round: Series C (Jun 28, 2021)
- Investors on record: 4

## About

Based in Wisconsin, US, SHINE Technologies, LLC was founded in 2005 by founder Greg Piefer. The company has 30 employees and also has offices in Monona, and its existing facility produces the therapeutic medical isotope lutetitum-177 (Lu-177). 

In February 2026, SHINE Technologies, LLC raised USD 240 million in venture funding led by new investor NantWorks, with participation from new investors Pelican Energy Partners and Sumitomo Corporation of Americas. Returning investors Deerfield Management, Fidelity Investments, Oaktree Capital Management and other unspecified investors also participated in the round.

The company's platform generates a variety of radioactive isotopes that are utilized to diagnose and cure a number of healthcare concerns, allowing physicians to effectively treat diseases such as cancer, thyroid disorders, deep vein thrombosis, circulatory difficulties, and chronic obstructive lung disease. Shine Medical Technologies offers Molybdenum-99, Iodine-131 (131I), Xenon-133 (133Xe), Iodine-125 (125I), and Lutetium-177 (177Lu) used for diagnosing patients. The company generates revenue by selling medical isotopes into the global market. The company is building a fusion-based medicinal isotope manufacturing plant in Janesville, Wisconsin, to manufacture molybdenum 99 (Mo-99). The company also broke construction on a large-scale therapeutic isotope facility, which will generate Lu-177 and is scheduled to be operational in mid-2022.

## Funding rounds

- Series C, Jun 28, 2021, $150M — Fidelity Investments, Alumni Ventures Group, Koch Disruptive Technologies, Baillie Gifford

## Investors

- Fidelity Investments (https://capitalatlas.ai/funds/fidelity-investments) — Series C
- Alumni Ventures Group (https://capitalatlas.ai/funds/alumni-ventures-group) — Series C
- Koch Disruptive Technologies (https://capitalatlas.ai/funds/koch-disruptive-technologies) — Series C
- Baillie Gifford (https://capitalatlas.ai/funds/baillie-gifford) — Series C